Original language | English |
---|---|
Article number | 58 |
Journal | Blood Cancer Journal |
Volume | 10 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2020 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. / Mina, R; Belotti, A; Petrucci, MT; Zambello, R; Capra, A; Di Lullo, G; Ronconi, S; Pescosta, N; Grasso, M; Monaco, F; Cellini, C; Gobbi, M; Ballanti, S; de Fabritiis, P; Mosca-Siez, ML; Marchetti, M; Liberati, AM; Offidani, M; Giuliani, N; Ria, R; Musto, P; Romano, A; Sonneveld, Pieter; Boccadoro, M; Larocca, A.
In: Blood Cancer Journal, Vol. 10, No. 5, 58, 2020.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
AU - Mina, R
AU - Belotti, A
AU - Petrucci, MT
AU - Zambello, R
AU - Capra, A
AU - Di Lullo, G
AU - Ronconi, S
AU - Pescosta, N
AU - Grasso, M
AU - Monaco, F
AU - Cellini, C
AU - Gobbi, M
AU - Ballanti, S
AU - de Fabritiis, P
AU - Mosca-Siez, ML
AU - Marchetti, M
AU - Liberati, AM
AU - Offidani, M
AU - Giuliani, N
AU - Ria, R
AU - Musto, P
AU - Romano, A
AU - Sonneveld, Pieter
AU - Boccadoro, M
AU - Larocca, A
PY - 2020
Y1 - 2020
U2 - 10.1038/s41408-020-0326-1
DO - 10.1038/s41408-020-0326-1
M3 - Article
VL - 10
JO - Blood Cancer Journal
JF - Blood Cancer Journal
SN - 2044-5385
IS - 5
M1 - 58
ER -